Related Experiment Video
Updated: Aug 12, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
[Balloon dilatation of the pulmonary valve. Short-, middle- and long-term results]
1Abteilung Pädiatrische Kardiologie Klinik mit Poliklinik für Kinder und Jugendliche, Friedrich-Alexander Universität Erlangen-Nürnberg. Gernot.Buheitel@Kinder.imed.uni-erlangen.de
Insights
Balloon dilatation effectively treats pulmonary valve stenosis, significantly reducing pressure gradients. This procedure is safe and offers lasting results, particularly for typical and critical cases in infants.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Pulmonary valve stenosis (PVS) is a significant congenital heart defect.
- Effective treatment options for PVS are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the immediate and long-term efficacy of balloon dilatation for pulmonary valve stenosis.
- To assess the safety and outcomes across different types of PVS.
Main Methods:
- Retrospective analysis of 111 patients (1 day-18 years) undergoing pulmonary valve balloon dilatation.
- Patients categorized into four groups: typical PVS, dysplastic PVS, critical PVS, and pulmonary atresia.
- Exclusion of patients with complex congenital heart disease.
Main Results:
- Average systolic transvalvular gradient reduced by 60% (68.5 to 27.2 mmHg) post-procedure.
- 80% of patients achieved sufficient treatment via transcatheter balloon dilatation.
- High success rates observed in typical and critical PVS groups, with fewer benefits in dysplastic PVS and pulmonary atresia.
Conclusions:
- Balloon dilatation is a secure and effective treatment for pulmonary valve stenosis.
- Optimal outcomes are achieved in typical PVS and critical PVS in newborns/infants.
- The procedure demonstrates a low rate of major complications (7.3%) with no lasting residuals or deaths.
Background:
Immediate and long-term results after balloon dilatation of pulmonary valve stenosis in our unit.
Methods And Patients:
All 111 patients (1 day-18 years) who have had balloon dilatation of a pulmonary valvar stenosis between 12/1987 and 8/1997 were divided into 4 groups: Typical valvar pulmonary stenosis (group A; n = 78), stenosis with dysplastic pulmonary valve (group B; n = 10), critical pulmonary stenosis (group C; n = 16) and pulmonary atresia after transcatheter or operative opening of the valve (group D; n = 7). Patients with pulmonary stenosis and complex congenital heart disease were excluded.
Results:
The average systolic transvalvular gradient was reduced from 68.5 to 27.2 mmHg (60%) immediately after balloon dilatation. After a follow up of 48.8 +/- 37 months 101 patients could be reevaluated. In group A (n = 69 at FU) and C (n = 16 at FU) 81% showed a systolic transvalvular gradient < 30 mmHg after one and 83% (A) respective 94% (C) after two balloon dilatations. In group B (n = 9 at FU) 44% exhibited a systolic gradient < 30 mmHg after one and 56% after two balloon dilatations. In group D (n = 7 at FU) 57% showed a systolic gradient < 30 mmHg with no further improvement by a second dilatation. Over all, 80% of our patients could be treated sufficiently by transcatheter means. The rate of major complications was 7.3% with no lasting residuals at follow up and no deaths.
Conclusion:
Balloon dilatation of the pulmonary valve is secure and effective. Best results are obtained in patients with typical pulmonary valve stenosis and in newborns and infants with critical pulmonary valve stenosis.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

